Summary
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of acquired immunodeficiency syndrome (AIDS). HIV-1 can infect human brain macrophages and microglial cells, causing HIV-associated dementia, or neuroAIDS, an increasingly common disorder of the central nervous system (CNS) that affects 20% of HIV-1-infected individuals. Current treatments for neuroAIDS are hampered by the poor efficiency of many antiretroviral drugs to cross the blood-brain barrier (BBB). Circulating blood monocytes and their derived macrophages are known to migrate across the BBB and enter the CNS under normal physiologic conditions and certain circumstances; some of these cells can subsequently mature into long-lived tissue-resident brain macrophages and microglia. Thus, the natural homing/migratory properties of blood monocyte-derived macrophages (MDM) can be potentially utilized as an effective genetic tool for delivering anti-HIV-1 genes to the CNS in a noninvasive and nonsurgical manner. To test and establish this macrophage-based gene therapy for the CNS, we have constructed and generated high-titered defective lentiviral vectors (DLV) expressing enhanced green fluorescent protein (GFP) as a reporter and optimized protocols for the isolation and long-term cultivation of primary MDM from humans and mice. We have demonstrated that primary cultures of human and mouse MDM can be efficiently modified in vitro using GFP-DLV vectors without apparently adverse effects on cellular biological properties. We have also shown that primary mouse MDM can enter the brain. The efficiency of CNS uptake of these cells can be enhanced through the use of bradykinin or a hypertonic mannitol solution for transient disruption of the BBB. These experimental methods and findings lay the initial groundwork for future in vivo studies on the ability of GFP-DLV-modified blood MDM to introduce anti-HIV-1 and neuroprotective genes into the CNS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.Q., Fuhrer, J., Satten, J.A., Aschman, D.J., and Holmberg, S.D. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853–60.
Masliah, E., DeTeresa, R.M., Mallory, M.E., and Hansen, L.A. (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS. 14:69–74.
Portegies, P., Solod, L., Cinque, P., et al (2004) Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur. J. Neurol. 11:297–304.
Dore, G.J., McDonald, A., Li, Y., Kaldor, J.M., Brew, B.J., et al (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 17:1539–45.
Neuenburg, J.K., Brodt, H.R., Herndier, B.G., Bickel, M, Bacchetti, P., Price, R.W., Grant, R.M., and Schlote, W. (2002) HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31:171–7.
Rutherford, M.S., Witsell, A., and Schook, L.B. (1993) Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukoc. Biol. 53(5):602–18.
Pereira, C.F., and Nottet, H.S.L.M. (2000) The blood-brain barrier in HIV-associated dementia. NeuroAids. 3:1–8.
Zhu, T.F. (2000) HIV-1 genotypes in peripheral blood monocytes. J. Leukoc. Biol. 68:338–44.
Priller, J., Flugel, A., Wehner, T., Boentert, M., Haas, C.A., Prinz, M., et-al. (2001) Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7:1356–61.
Ross, J.A., and Auger, M.J. (2002) The biology of the macrophage. In: Burke, B. and Lewis, C.E. (eds), The Macrophage. Oxford University Press. Oxford, New York. Pp. 1–72.
Fischer-Smith, T., and Rappaport, J. (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev. Mol. Med. 27:1–26.
Eugenin, E.A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T.M., and Berman, J.W. (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26:1098–106.
Zeng, L.B., Planelles, Y., Sui, Z., Gartner, S., Maggirwar, S.B., Dewhurst, S., Ye, L.B., Nerurkar, V.R., Yanagihara, R., and Lu, Y. (2006a) Human immunodeficiency virus type 1 (HIV-1) based defective lentiviral vectors efficiently transduce human monocyte-derived macrophages and suppress replication of wild-type HIV-1. J. Gene Med. 8:18–28.
Zeng, L.B., Yang, S.M., Wu, C.X., Ye, L.B., and Lu, Y. (2006b) Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-1-based defective lentiviral vectors. J. Virol. Methods. 134:66–73.
Wu, J.M., Yang, S.M., Luo, H.Y., Nguyen, M., Zeng, L.B., and Lu, Y. (2006) Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice. Brain Res. 1098:79–85.
Wu, C.X., and Lu, Y., and (2007) Addition of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency. Cell. Mol. Biol. 53(4):67–74.
Acknowledgments
This study was supported by grants from the National Institutes of Health (S11NS043499 and G12RR003061) and by the Hawaii Community Foundation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lu, Y. (2009). GFP-Lentiviral Vectors Targeting for NeuroAIDS. In: Hicks, B.W. (eds) Viral Applications of Green Fluorescent Protein. Methods in Molecular Biology™, vol 515. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-559-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-559-6_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-934115-87-9
Online ISBN: 978-1-59745-559-6
eBook Packages: Springer Protocols